Man Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.6M | Buy |
126,291
+48,517
| +62% | +$10.1M | 0.04% | 440 |
|
|
2026
Q1 | $17.5M | Sell |
77,774
-121,994
| -61% | -$30.4M | 0.03% | 560 |
|
|
2025
Q4 | $48.1M | Buy |
199,768
+77,653
| +64% | +$19.9M | 0.08% | 256 |
|
|
2025
Q3 | $33.4M | Buy |
122,115
+76,034
| +165% | +$20.8M | 0.06% | 346 |
|
|
2025
Q2 | $11.9M | Sell |
46,081
-88,844
| -66% | -$21.2M | 0.02% | 708 |
|
|
2025
Q1 | $30.2M | Buy |
134,925
+83
| +0.1% | +$19.4K | 0.08% | 304 |
|
|
2024
Q4 | $30.8M | Sell |
134,842
-15,247
| -10% | -$3.67M | 0.08% | 288 |
|
|
2024
Q3 | $36.6M | Buy |
150,089
+59,329
| +65% | +$13.3M | 0.1% | 265 |
|
|
2024
Q2 | $17.4M | Sell |
90,760
-104,541
| -54% | -$21.2M | 0.04% | 483 |
|
|
2024
Q1 | $38.7M | Buy |
195,301
+162,500
| +495% | +$29.8M | 0.1% | 232 |
|
|
2023
Q4 | $5.64M | Buy |
+32,801
| New | +$5.04M | 0.02% | 892 |
|
|
2023
Q3 | – | Sell |
-477,021
| Closed | -$86.3M | – | 157 |
|
|
2023
Q2 | $104M | Buy |
+477,021
| New | +$106M | 0.32% | 54 |
|
|
2023
Q1 | – | Sell |
-130,823
| Closed | -$28.4M | – | 48 |
|
|
2022
Q4 | $27.2M | Buy |
130,823
+129,881
| +13,788% | +$28.5M | 0.1% | 261 |
|
|
2022
Q3 | $206K | Buy |
+942
| New | +$214K | ﹤0.01% | 1766 |
|
|
2022
Q2 | – | Sell |
-35,057
| Closed | -$7.46M | – | 1142 |
|
|
2022
Q1 | $8.5M | Sell |
35,057
-40,381
| -54% | -$9.77M | 0.03% | 670 |
|
|
2021
Q4 | $19.6M | Buy |
75,438
+9,155
| +14% | +$2.38M | 0.06% | 377 |
|
|
2021
Q3 | $17.5M | Buy |
66,283
+20,054
| +43% | +$5.48M | 0.06% | 380 |
|
|
2021
Q2 | $11.4M | Buy |
46,229
+24,453
| +112% | +$5.14M | 0.04% | 515 |
|
|
2021
Q1 | $4.22M | Buy |
21,776
+905
| +4% | +$181K | 0.02% | 774 |
|
|
2020
Q4 | $4.44M | Sell |
20,871
-36,184
| -63% | -$7.21M | 0.02% | 875 |
|
|
2020
Q3 | $9.78M | Buy |
57,055
+42,905
| +303% | +$7.92M | 0.04% | 480 |
|
|
2020
Q2 | $2.72M | Buy |
14,150
+10,652
| +305% | +$1.74M | 0.01% | 937 |
|
|
2020
Q1 | $515K | Sell |
3,498
-58,603
| -94% | -$9.33M | ﹤0.01% | 1273 |
|
|
2019
Q4 | $9.62M | Sell |
62,101
-30,523
| -33% | -$4.4M | 0.03% | 705 |
|
|
2019
Q3 | $12.5M | Buy |
92,624
+55,543
| +150% | +$7.28M | 0.05% | 472 |
|
|
2019
Q2 | $4.53M | Sell |
37,081
-35,346
| -49% | -$3.92M | 0.02% | 988 |
|
|
2019
Q1 | $7.53M | Sell |
72,427
-152,461
| -68% | -$15.7M | 0.03% | 705 |
|
|
2018
Q4 | $25.6M | Sell |
224,888
-62,010
| -22% | -$6.64M | 0.11% | 188 |
|
|
2018
Q3 | $33.1M | Buy |
286,898
+119,827
| +72% | +$13.1M | 0.12% | 173 |
|
|
2018
Q2 | $17.3M | Buy |
167,071
+40,006
| +31% | +$4.05M | 0.07% | 317 |
|
|
2018
Q1 | $12.5M | Buy |
+127,065
| New | +$12M | 0.06% | 390 |
|
Other funds holding RMD
Man Group's RMD Position: Q2 2026 in Review
Man Group increased its ResMed (RMD) stake by 62% in Q2 2026, buying an estimated $10.1M and bringing the position to 126,291 shares worth $24.6M. The position accounts for 0.04% of the portfolio, ranked #440.
Man Group first reported a position in RMD in Q1 2018 and has held it in 31 quarters since. The position peaked at $104M in Q2 2023. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Man Group held 126,291 shares of ResMed worth $24.6M as of Q2 2026.
- Man Group bought 48,517 ResMed shares in Q2 2026, an estimated $10.1M.
- ResMed made up 0.04% of Man Group's portfolio in Q2 2026, its #440 holding.
- Man Group first reported a position in ResMed in Q1 2018 and has held it in 31 quarters since.
- Man Group's ResMed position peaked at $104M in Q2 2023.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.